Immunomedics (IMMU) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kitty2 who wrote (309)	12/21/2004 10:22:41 PM
From: idahoranch1	of 371

<<can immu get straight into phase3 for lupus with 17 treated patients in germany and if so how>> Good question and one that I kept asking. They really seem to believe that they are in the process, working with the FDA, of starting a pivotal trial. And it was 14 patients in Germany. <<they would need a partner to fund phase 3 right? If no partner no phase 3 right?>> They need a partner or someone with deep pockets to run the pivotal trial, yes. <<So it really all comes down to one issue that must occur at least in the first half of the year actually first qtr and that is get a big pharma partner>> It MUST occur before the run out of money, which would be a year or so. Logically, it NEEDS to happen in the next 3 to 6 months, but the sooner the better.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next